NOVEL STRATEGY IN THE RADIOTHERAPY OF METASTATIC BRAIN TUMORS: SIMULTANEOUS WHOLE BRAIN RADIOTHERAPY AND INTEGRATED STEREOTACTIC RADIOSURGERY

被引:0
作者
Kalincsak Judit [1 ]
Laszlo Zoltan [1 ]
Sebestyen Zsolt [1 ]
Kovacs Peter [1 ]
Horvath Zsolt [2 ]
Doczi Tamas [2 ]
Mangel Laszlo [1 ]
机构
[1] Pecsi Tud Egyet, Klin Kozpont, Onkoterapias Int, H-7624 Pecs, Hungary
[2] Pecsi Tud Egyet, Klin Kozpont, Idegsebeszeti Klin, H-7624 Pecs, Hungary
来源
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE | 2015年 / 68卷 / 11-12期
关键词
brain metastasis; dynamic arc therapy; whole brain radiotherapy; stereotactic radiosurgery; integrated boost; MODULATED ARC THERAPY; RADIATION-THERAPY; PHASE-III; GLIOBLASTOMA; MANAGEMENT; CYBERKNIFE;
D O I
10.18071/isz.isz.68.391
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose - Treatment of central nervous system (CNS) tumors has always played an important role in development of radiotherapy techniques. Precise patient immobilisation, non-coplanar field arrangement, conformal treatment, arc therapy, radiosurgery, application of image fusion to radiation planning or re-irradiation were first introduced into clinical routine in the treatment of brain tumors. Methods - A modern multifunctional radiation instrument, Novalis TX has been installed at the University of Pecs two years ago. New methods, such as real time 3D image guided therapy, dynamic arc therapy and ultra-conformity offer further progress in treatment of CNS tumors. Whole brain irradiation and simultaneous fractionated stereotactic radio surgery or integrated boost seem to be an optimal method in the treatment of not only soliter or oligo, but even a higher number (4-9) and not typically radiosensitive brain metastases. The new treatment strategy is illustrated by presentation of four case histories. Results - Treatment protocol was completed in all cases. Treatment period of 1.5 to 3 weeks, and treatment time of only a few minutes were not stressful for the patients. A quite remarkable clinical improvement as to general condition of the patients was experienced in three cases. Followup images confirmed either remission or a stable disease. Conclusions - Simultaneous whole brain radiotherapy and integrated stereotactic radiosurgery is a reproducible, safe method that offers an effective irradiation with delivery of definitive dosage even in cases with radio-insensitive brain metastasis.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 39 条
  • [1] Intensity-modulated radiation therapy in newly diagnosed glioblastoma: A systematic review on clinical and technical issues
    Amelio, Dante
    Lorentini, Stefano
    Schwarz, Marco
    Amichetti, Maurizio
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 361 - 369
  • [2] Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience
    Awad, Raef
    Fogarty, Gerald
    Hong, Angela
    Kelly, Patricia
    Ng, Diana
    Santos, Daniel
    Haydu, Lauren
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [3] Systematic review of stereotactic radiotherapy for high-grade gliomas
    Clavier, J. -B.
    Voirin, J.
    Kehrli, P.
    Noel, G.
    [J]. CANCER RADIOTHERAPIE, 2010, 14 (08): : 739 - 754
  • [4] Daróczi B, 2013, IDEGGYOGY SZEMLE, V66, P391
  • [5] Dobi A, 2009, MAGY ONKOL, V53, P192
  • [6] Dobi A, 2011, MAGY ONKOL, V55, P141
  • [7] MULTIPLE INTRACRANIAL MELANOMA METASTASES TREATED WITH SURGERY AND RADIOSURGERY WITH LONG-TERM CONTROL - A CASE-REPORT
    FEDORCSAK, I
    SIPOS, L
    HORVATH, A
    KONTRA, G
    BOGNAR, L
    OSZTIE, E
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1993, 16 (02) : 173 - 176
  • [8] Gaal Sz, 2009, MAGY ONKOL, V53, P196
  • [9] The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
    Gaspar, Laurie E.
    Mehta, Minesh P.
    Patchell, Roy A.
    Burri, Stuart H.
    Robinson, Paula D.
    Morris, Rachel E.
    Ammirati, Mario
    Andrews, David W.
    Asher, Anthony L.
    Cobbs, Charles S.
    Kondziolka, Douglas
    Linskey, Mark E.
    Loeffler, Jay S.
    McDermott, Michael
    Mikkelsen, Tom
    Olson, Jeffrey J.
    Paleologos, Nina A.
    Ryken, Timothy C.
    Kalkanis, Steven N.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (01) : 17 - 32
  • [10] Temozolomide for high grade glioma
    Hart, Michael G.
    Garside, Ruth
    Rogers, Gabriel
    Stein, Ken
    Grant, Robin
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (04):